The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CSCGlobal Capital Markets (Singapore) Pte. Ltd
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CSCGlobal Capital Markets (Singapore) Pte. Ltd., acting as Security Agent for a lenders' group, filed a SEBI SAST Regulation 29(2) disclosure reporting the release of encumbrance on 3,41,48,000 equity shares (8.93% of capital) of Cohance Lifesciences. The release was triggered because promoter Jusmiral Holdings Limited sold those shares via an on-market sale on September 18, 2025. As a result, Jusmiral's stake in Cohance dropped from 33.08% to 24.15% (32.75% to 23.91% on a fully diluted basis). A separate 33.34% encumbrance on Berhyanda shares remains unchanged. CSCGlobal clarified it is not a promoter and Jusmiral Holdings never created a direct pledge on Cohance shares — the encumbrance arose from loan covenants under a Notes Purchase Agreement.
Promoter Jusmiral Holdings has executed a sizeable on-market sale of nearly 9% of Cohance Lifesciences, cutting its holding to 24.15%. For shareholders, this is a significant supply event that may pressure the stock in the short term and signals promoter-level portfolio rebalancing. The release of pledge simply follows the sale, so it is not an independent negative trigger, but the underlying promoter sell-down is the key takeaway.